 WESTLAKE VILLAGE, Calif., June 01, 2021 GLOBE NEWSWIRE -- Arcutis Biotherapeutics, Inc. Nasdaq: ARQT, a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Rajvir Raj Madan has joined the company as its first Chief Digital and Information Officer. In this role, Mr. Madan will be responsible for providing the vision, strategic direction and overall leadership of digital, dataanalytics and information technology initiatives across Arcutis. 